XML 73 R63.htm IDEA: XBRL DOCUMENT
v3.23.3

Subsequent Events - Additional Information (Details) - USD ($) $ / shares in Units, $ in Thousands |  |  |  | 2 Months Ended | 9 Months Ended |
--- | --- | --- | --- | --- | --- | ---
Nov. 09, 2023 | Oct. 03, 2023 | Sep. 29, 2023 | Nov. 30, 2023 | Sep. 30, 2023 | Dec. 31, 2022
Subsequent Event [Line Items] |  |  |  |  |  |
Common stock, shares authorized |  |  |  |  | 490,000,000 | 490,000,000
Shares exercised during the period |  |  |  |  | 8,000 |
Preferred stock, par value |  |  |  |  | $ 0.0001 | $ 0.0001
Preferred Tranche A Warrants [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Warrants exercisable, description |  | The Preferred Tranche A Warrants are exercisable commencing on the Issuance Date (as defined in the Form of Preferred Tranche A Warrant) until the earlier of (i) fifteen (15) trading days following the date of public announcement of the fulsome data set from the Sanofi S.A. Protect trial and (ii) December 15, 2023. If any purchaser in the September 2023 Offering fails to exercise their Preferred Tranche A Warrant in full prior to its expiration date, such purchaser will forfeit all Preferred Tranche A Warrants, Preferred Tranche B Warrants and Preferred Tranche C Warrants issued to such purchaser. |  |  |  |
Series A-1 Preferred Stock [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Preferred stock, par value |  |  | $ 0.63 |  |  |
Securities Purchase Agreement [Member] | Series A-1 Preferred Stock [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Preferred stock, par value |  |  | $ 0.0001 |  |  |
Gross proceeds from private placement |  |  | $ 7,500 |  |  |
Securities Purchase Agreement [Member] | Series A-2 Preferred Stock [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Preferred stock, par value |  |  | $ 0.0001 |  |  |
Securities Purchase Agreement [Member] | Private Placement [Member] | Forecast [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Aggregate offering price |  |  |  | $ 67,100 |  |
Securities Purchase Agreement [Member] | Private Placement [Member] | Preferred Tranche A Warrants [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Preferred stock, par value |  |  | $ 0.0001 |  |  |
Aggregate exercise price |  |  | $ 70,500 |  |  |
Securities Purchase Agreement [Member] | Private Placement [Member] | Preferred Tranche A Warrants [Member] | Forecast [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Number of shares issued |  |  |  | 59,654 |  |
Shares exercised during the period |  |  |  | 59,654 |  |
Aggregate exercise price |  |  |  | $ 59,700 |  |
Securities Purchase Agreement [Member] | Private Placement [Member] | Preferred Tranche B Warrants [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Preferred stock, par value |  |  | $ 0.0001 |  |  |
Aggregate exercise price |  |  | $ 52,000 |  |  |
Securities Purchase Agreement [Member] | Private Placement [Member] | Preferred Tranche C Warrants [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Preferred stock, par value |  |  | $ 0.0001 |  |  |
Aggregate exercise price |  |  | $ 130,000 |  |  |
Securities Purchase Agreement [Member] | Private Placement [Member] | Series A-1 Preferred Stock [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Number of shares issued |  |  | 7,500 |  |  |
Preferred stock, par value |  |  | $ 0.0001 |  |  |
Aggregate offering price |  |  | $ 7,500 |  |  |
Subsequent Event [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Common stock, shares authorized |  | 800,000,000 |  |  |  |
Subsequent Event [Member] | Preferred Tranche B Warrants [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Warrants exercisable, description |  | The Preferred Tranche B Warrants are exercisable commencing on the Exercisability Date (as defined in the Form of Preferred Tranche B Warrant) until the later of (i) 15 days following the Company’s announcement of data from its SAB-142-101 clinical trial and (ii) March 31, 2025. |  |  |  |
Subsequent Event [Member] | Preferred Tranche C Warrants [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Warrants exercisable, description |  | The Preferred Tranche C Warrants are exercisable commencing on the Exercisability Date (as defined in the Form of Preferred Tranche C Warrant) until the five (5) year anniversary of the Exercisability Date. |  |  |  |
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member] | Preferred Tranche A Warrants [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Shares exercised during the period | 16,269 |  |  |  |  |
Unexercised warrants | 27,115 |  |  |  |  |
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member] | Preferred Tranche B Warrants [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Shares exercised during the period | 10,846 |  |  |  |  |
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member] | Preferred Tranche C Warrants [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Shares exercised during the period | 27,115 |  |  |  |  |
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member] | Series A-1 Preferred Stock [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Number of shares issued | 59,654 | 7,500 |  |  |  |
Aggregate exercise price | $ 59,650 |  |  |  |  |
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member] | Series A-3 Preferred Stock [Member] | Preferred Tranche B Warrants [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Outstanding warrants | 42,846 |  |  |  |  |
Aggregate exercise price | $ 42,850 |  |  |  |  |
Subsequent Event [Member] | Securities Purchase Agreement [Member] | Private Placement [Member] | Series A-3 Preferred Stock [Member] | Preferred Tranche C Warrants [Member] |  |  |  |  |  |
Subsequent Event [Line Items] |  |  |  |  |  |
Outstanding warrants | 107,115 |  |  |  |  |
Aggregate exercise price | $ 107,100 |  |  |  |  |

X
- Definition Class of warrant or right, aggregate exercise price of warrants. + References No definition available. + Details
Name: | sabs_ClassOfWarrantOrRightAggregateExercisePriceOfWarrants
Namespace Prefix: | sabs_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Warrants exercisable description. + References No definition available. + Details
Name: | sabs_WarrantsExercisableDescription
Namespace Prefix: | sabs_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Number of warrants or rights outstanding. + References No definition available. + Details
Name: | us-gaap_ClassOfWarrantOrRightOutstanding
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition The maximum number of common shares permitted to be issued by an entity's charter and bylaws. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(16)(a)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147479617/946-210-S99-1 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_CommonStockSharesAuthorized
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Definition Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-13 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_PreferredStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition The cash inflow associated with the amount received from entity's raising of capital via private rather than public placement. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 45 -Paragraph 14 -Subparagraph (a) -SubTopic 10 -Topic 230 -Publisher FASB -URI https://asc.fasb.org//1943274/2147482740/230-10-45-14 + Details
Name: | us-gaap_ProceedsFromIssuanceOfPrivatePlacement
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cash received on stock transaction after deduction of issuance costs. + References No definition available. + Details
Name: | us-gaap_SaleOfStockConsiderationReceivedOnTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. + References No definition available. + Details
Name: | us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Number of share options (or share units) exercised during the current period. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -SubTopic 10 -Topic 505 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481112/505-10-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(02) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(28)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480008/505-10-S99-1 Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 210 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -Publisher FASB -URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1 + Details
Name: | us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 830 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147481674/830-30-50-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 855 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org//1943274/2147483399/855-10-50-2 + Details
Name: | us-gaap_SubsequentEventLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=sabs_PreferredTrancheAWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=sabs_SeriesAOneConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_TypeOfArrangementAxis=sabs_SecuritiesPurchaseAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=sabs_SeriesATwoConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsidiarySaleOfStockAxis=us-gaap_PrivatePlacementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | srt_StatementScenarioAxis=srt_ScenarioForecastMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=sabs_PreferredTrancheBWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_ClassOfWarrantOrRightAxis=sabs_PreferredTrancheCWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_SubsequentEventTypeAxis=us-gaap_SubsequentEventMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_StatementClassOfStockAxis=sabs_SeriesAThreeConvertiblePreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |